News Topic - Wyeth
Articles 1 - 10 of most recent articles
Glaxo, Pfizer and Wyeth Exceed Wall Street’s Expectations
Although all three firms face major threats from generic competition, results show that demand for medicines is holding up well at a time of economic downturn.
New York Times – Jul 24, 2008 03:10 AM [GMT] ¦ comment?
found in Business
Although all three firms face major threats from generic competition, results show that demand for medicines is holding up well at a time of economic downturn.
New York Times – Jul 24, 2008 03:10 AM [GMT] ¦ comment?
found in Business
Weak dollar, foreign sales boost drugmakersAP - Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies — nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar.
Yahoo! – Jul 23, 2008 11:42 PM [GMT] ¦ comment?
found in Business: Companies
Wyeth profit crimped by generic competition, restructuring
Wyeth raises its full-year forecast but reports modestly lower second-quarter earnings, due in part to restructuring costs and increased generic competition for its popular heartburn medication Protonix.
MarketWatch.com – Jul 23, 2008 4:36 PM [GMT] ¦ comment?
found in Business
Wyeth raises its full-year forecast but reports modestly lower second-quarter earnings, due in part to restructuring costs and increased generic competition for its popular heartburn medication Protonix.
MarketWatch.com – Jul 23, 2008 4:36 PM [GMT] ¦ comment?
found in Business
Cost-Cutting Boosts Pfizer
Pfizer's net income more than doubled amid cost-cutting and lower restructuring charges. Wyeth posted a 6.4% decrease in net income, weighed down by restructuring costs.
Wall Street Journal – Jul 23, 2008 3:27 PM [GMT] ¦ comment?
found in Health
Pfizer's net income more than doubled amid cost-cutting and lower restructuring charges. Wyeth posted a 6.4% decrease in net income, weighed down by restructuring costs.
Wall Street Journal – Jul 23, 2008 3:27 PM [GMT] ¦ comment?
found in Health
Biotech Stocks: Drug stocks inch up; Wyeth climbs on financial forecast
Drug stocks edge higher as shares of Wyeth gain after the company raises its 2008 financial forecast.
MarketWatch.com – Jul 23, 2008 2:14 PM [GMT] ¦ comment?
found in Business
Drug stocks edge higher as shares of Wyeth gain after the company raises its 2008 financial forecast.
MarketWatch.com – Jul 23, 2008 2:14 PM [GMT] ¦ comment?
found in Business
Top drug companies' earnings beat forecasts
Reuters - The world's two biggest drugmakers, Pfizer Inc and GlaxoSmithKline Plc , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.
Yahoo! – Jul 23, 2008 1:59 PM [GMT] ¦ comment?
found in Business
Reuters - The world's two biggest drugmakers, Pfizer Inc and GlaxoSmithKline Plc , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.
Yahoo! – Jul 23, 2008 1:59 PM [GMT] ¦ comment?
found in Business
Drug stocks inch higher; Wyeth gains after raising forecast
BOSTON (MarketWatch) -- Drug stocks edged higher early Wednesday as shares of Wyeth gained after it raised its 2008 financial forecast. The Amex Pharmaceutical Index and the Amex Biotechnology Index were both up marginally at 304.0 and 833.8, respectively. Wyeth shares rose almost 4% to $46.37. Although the company reported modestly lower second-quarter earnings, Wyeth also increased its 2008 adjusted earnings forecast to $3.47 to $3.55 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
MarketWatch.com – Jul 23, 2008 1:53 PM [GMT] ¦ comment?
found in Business: Markets
BOSTON (MarketWatch) -- Drug stocks edged higher early Wednesday as shares of Wyeth gained after it raised its 2008 financial forecast. The Amex Pharmaceutical Index and the Amex Biotechnology Index were both up marginally at 304.0 and 833.8, respectively. Wyeth shares rose almost 4% to $46.37. Although the company reported modestly lower second-quarter earnings, Wyeth also increased its 2008 adjusted earnings forecast to $3.47 to $3.55 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
MarketWatch.com – Jul 23, 2008 1:53 PM [GMT] ¦ comment?
found in Business: Markets
Wyeth Edges Out Beat, Raises Guidance
On an adjusted basis, the drugmaker beats Wall Street estiamtes by a penny a share.
TheStreet.com – Jul 23, 2008 1:30 PM [GMT] ¦ comment?
found in Business: Investing
On an adjusted basis, the drugmaker beats Wall Street estiamtes by a penny a share.
TheStreet.com – Jul 23, 2008 1:30 PM [GMT] ¦ comment?
found in Business: Investing
Wyeth Profit Falls 7 Percent, but Beats Estimates
Wyeth said earnings fell 7 percent, hurt by generic forms of its Protonix ulcer drug, although results beat estimates.
New York Times – Jul 23, 2008 1:03 PM [GMT] ¦ comment?
found in Business
Wyeth said earnings fell 7 percent, hurt by generic forms of its Protonix ulcer drug, although results beat estimates.
New York Times – Jul 23, 2008 1:03 PM [GMT] ¦ comment?
found in Business
Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
Read full story for latest details.
PR Newswire – Jul 23, 2008 11:37 AM [GMT] ¦ comment?
found in Top Stories: Press Releases
Read full story for latest details.
PR Newswire – Jul 23, 2008 11:37 AM [GMT] ¦ comment?
found in Top Stories: Press Releases